These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3548720)

  • 41. N-phosphonacetyl-L-isoasparagine a potent and specific inhibitor of Escherichia coli aspartate transcarbamoylase.
    Eldo J; Cardia JP; O'Day EM; Xia J; Tsuruta H; Kantrowitz ER
    J Med Chem; 2006 Oct; 49(20):5932-8. PubMed ID: 17004708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectral alterations associated with the ligand-promoted gross conformational change in aspartate transcarbamoylase.
    Hu CY; Howlett GJ; Schachman HK
    J Biol Chem; 1981 May; 256(10):4998-5004. PubMed ID: 7014567
    [No Abstract]   [Full Text] [Related]  

  • 43. Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.
    Coudray L; Kantrowitz ER; Montchamp JL
    Bioorg Med Chem Lett; 2009 Feb; 19(3):900-2. PubMed ID: 19097895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the essential arginine residue in Escherichia coli ornithine and aspartate transcarbamylases.
    Fortin AF; Hauber JM; Kantrowitz ER
    Biochim Biophys Acta; 1981 Nov; 662(1):8-14. PubMed ID: 7030401
    [No Abstract]   [Full Text] [Related]  

  • 45. Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A.
    Jin L; Stec B; Lipscomb WN; Kantrowitz ER
    Proteins; 1999 Dec; 37(4):729-42. PubMed ID: 10651286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propagation of conformational changes in Ni(II)-substituted aspartate transcarbamoylase: effect of active-site ligands on the regulatory chains.
    Johnson RS; Schachman HK
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1995-9. PubMed ID: 6990418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectors of Escherichia coli aspartate transcarbamoylase differentially perturb aspartate binding rather than the T-R transition.
    Hsuanyu YC; Wedler FC
    J Biol Chem; 1988 Mar; 263(9):4172-81. PubMed ID: 3279030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The allosteric activator Mg-ATP modifies the quaternary structure of the R-state of Escherichia coli aspartate transcarbamylase without altering the T<-->R equilibrium.
    Fetler L; Vachette P
    J Mol Biol; 2001 Jun; 309(3):817-32. PubMed ID: 11397099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ligand-promoted strengthening of interchain bonding domains in catalytic subunits of aspartate transcarbamoylase.
    Burns DL; Schachman HK
    J Biol Chem; 1982 Oct; 257(20):12214-8. PubMed ID: 7118940
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolic resistance: the protection of enzymes against drugs which are tight-binding inhibitors by the accumulation of substrate.
    Christopherson RI; Duggleby RG
    Eur J Biochem; 1983 Aug; 134(2):331-5. PubMed ID: 6873066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide-protein interaction markedly alters the functional properties of the catalytic subunit of aspartate transcarbamoylase.
    Zhou BB; Schachman HK
    Protein Sci; 1993 Jan; 2(1):103-12. PubMed ID: 8443583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Products in the T-state of aspartate transcarbamylase: crystal structure of the phosphate and N-carbamyl-L-aspartate ligated enzyme.
    Huang J; Lipscomb WN
    Biochemistry; 2004 Jun; 43(21):6422-6. PubMed ID: 15157076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Replacement of Asp-162 by Ala prevents the cooperative transition by the substrates while enhancing the effect of the allosteric activator ATP on E. coli aspartate transcarbamoylase.
    Fetler L; Tauc P; Baker DP; Macol CP; Kantrowitz ER; Vachette P
    Protein Sci; 2002 May; 11(5):1074-81. PubMed ID: 11967364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzymatic synthesis of labeled carbamyl- aspartic acid.
    Kidder GW; Nolan LL
    Biochem Biophys Res Commun; 1975 Jul; 65(1):420-6. PubMed ID: 1147998
    [No Abstract]   [Full Text] [Related]  

  • 55. Three-dimensional structure of carbamoyl phosphate and succinate bound to aspartate carbamoyltransferase.
    Gouaux JE; Lipscomb WN
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4205-8. PubMed ID: 3380787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functionally important arginine residues of aspartate transcarbamylase.
    Kantrowitz ER; Lipscomb WN
    J Biol Chem; 1977 May; 252(9):2873-80. PubMed ID: 323257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Site-specific mutation of Tyr240----Phe in the catalytic chain of Escherichia coli aspartate transcarbamylase. Consequences for kinetic mechanism.
    Hsuanyu Y; Wedler FC; Kantrowitz ER; Middleton SA
    J Biol Chem; 1989 Oct; 264(29):17259-65. PubMed ID: 2677001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of the allosteric transition of aspartate transcarbamylase. Chemical quench studies.
    Kihara H; Barman TE; Jones PT; Moody MF
    J Mol Biol; 1984 Jul; 176(4):523-34. PubMed ID: 6379193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of the reaction catalyzed by the catalytic subunit of aspartate transcarbamylase. Kinetic studies with carbamyl phosphate as substrate.
    Heyde E; Nagabhushanam A; Morrison JF
    Biochemistry; 1973 Nov; 12(23):4718-26. PubMed ID: 4589945
    [No Abstract]   [Full Text] [Related]  

  • 60. Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.
    Lunev S; Bosch SS; Batista Fde A; Wrenger C; Groves MR
    Acta Crystallogr F Struct Biol Commun; 2016 Jul; 72(Pt 7):523-33. PubMed ID: 27380369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.